Skip to main content
Premium Trial:

Request an Annual Quote

Eureka Genomics, James Hutton Institute Co-develop Assay to Genotype Barley

NEW YORK (GenomeWeb News) – Eureka Genomics said today it is developing a custom assay for genotyping barley in collaboration with Scotland's James Hutton Institute.

The assay, which will be priced at $15 per sample, will allow for the identification of more than 400 SNPs in a single test, giving researchers the option of a low-cost method for identifying and optimizing traits such as yield, quantity, and environmental resilience for commercial crop production, Hercules, Calif.-based Eureka said. It plans to launch the assay next month in Europe and the US.

The assay will be developed based on next-generation sequencing and can be broadly applied to detect SNPS, copy number variations, presence/absence and methylation. It is compatible with DNA and RNA from almost any organism even when information about the genome is missing, Eureka said

"The collaboration has resulted in a very cost-effective, medium-throughput approach to single nucleotide polymorphism genotyping, a fundamental technology in both genetic studies and contemporary crop improvement programs worldwide," Robbie Waugh, head of genetics at the James Hutton Institute, said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.